2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Paper cited by two technology pages, indexed on Europe PMC as PubMed record 36017568 and published in European heart journal; the citing pages link this DOI, which is how the record was matched.
Overview
Europe PMC indexes no abstract for this record; the title is the only text available.
Indexed on Europe PMC as PubMed record 36017568 (DOI 10.1093/eurheartj/ehac244). Matched by DOI alone: two technology pages cite this DOI among their external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.
Two technology pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
- Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper.
Similar pages
not linked directly; found by shared links- TermCardiotoxicity (LVEF decline, cardiomyopathy)
Shares Strain echocardiography (global longitudinal strain), Troponin and natriuretic peptide monitoring during cancer treatment.
- TermAnthracyclines (doxorubicin, epirubicin)
Shares Strain echocardiography (global longitudinal strain), Troponin and natriuretic peptide monitoring during cancer treatment.
- TreatmentDexrazoxane
Shares Strain echocardiography (global longitudinal strain), Troponin and natriuretic peptide monitoring during cancer treatment.
- TrialChildhood Cancer Survivor Study (CCSS)
Shares Strain echocardiography (global longitudinal strain), Troponin and natriuretic peptide monitoring during cancer treatment.